Single-cell and spatial genomics technologies are transforming cancer research by providing unprecedented insights into tumor biology. These advanced tools allow scientists to analyze individual cells within tumors, revealing complex interactions and cellular states that drive cancer progression. The technology enables better understanding of drug resistance mechanisms and identification of new therapeutic targets. However, significant challenges remain before these methods can reach their full clinical potential, including sample preservation issues and analytical complexities.
